Sentinel Lymph Node Clinical Trial
Official title:
SEntine Lymph Node in earLY Ovarian Cancer
The present study aims at investigating the feasibility, the detection rate and the negative predictive value of sentinel node in predicting the presence or absence of lymph node metastasis in ovarian cancer patients
Patients with early stage ovarian cancer have a good prognosis. However, nearly 15% of the initially diagnosed as early stage ovarian cancers, will be upstaged after an appropriate surgical staging due to lymphatic metastasis, despite of preoperative radiological data. Therefore, complete pelvic and para-aortic lymphadenectomy in these patients represents a crucial procedure. On the other hand, nodal dissection may be associated with threatening intra- and post-operative complications. If feasible and accurate, the sentinel lymph node procedure could be a modality to avoid unnecessary radical lymphadenectomy without missing important information on nodal status. With the present study we aim at exploring the role of sentinel node dissection in early ovarian cancer patients. Patients with ovarian cancer macroscopically limited to the ovary (early ovarian cancer) will receive injection of a tracer (patent blue or indocyanine green) which have already been proven safe and extremely effective in several other gynecologic and non-gynecologic malignancies. Then the retroperitoneal spaces will be opened as for a standard lymphadenectomy procedure and the lymph node marked with the tracer will be identified. After dissection of the sentinel node, lymphadenectomy will be completed according to current guidelines. Operative data, pathological findings and accuracy of sentinel node in predicting nodal status will be registered. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05437380 -
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
|
N/A | |
Active, not recruiting |
NCT04303715 -
No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography
|
N/A | |
Completed |
NCT05498051 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
|
N/A | |
Active, not recruiting |
NCT06169787 -
Sentinel Lymph Nodes Biopsy in Cervical Cancer
|
||
Completed |
NCT03294330 -
SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer
|
Phase 3 | |
Not yet recruiting |
NCT04930692 -
A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"
|
N/A | |
Recruiting |
NCT03749707 -
HPV in Sentinel Lymph Nodes
|
N/A | |
Completed |
NCT03899441 -
Multimedia Aid Gynecologic Counseling and Consent
|
N/A | |
Recruiting |
NCT04826211 -
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
|
N/A | |
Not yet recruiting |
NCT06130241 -
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
|
N/A | |
Recruiting |
NCT04664582 -
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
|
N/A | |
Withdrawn |
NCT04487912 -
Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer
|
Phase 4 | |
Recruiting |
NCT05623280 -
Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.
|
||
Active, not recruiting |
NCT05359783 -
Sentinel Node Localization and Staging With Low Dose Superparamagnetic Iron Oxide
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04568941 -
Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer
|
N/A | |
Completed |
NCT03606616 -
Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients
|
||
Recruiting |
NCT02982148 -
Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer Patients
|
Phase 4 | |
Recruiting |
NCT06161428 -
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer
|
||
Completed |
NCT03900104 -
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
|
N/A | |
Recruiting |
NCT04671511 -
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
|
N/A |